GB201202497D0 - Medicinal applications of substituted hydroxytetronic acids - Google Patents
Medicinal applications of substituted hydroxytetronic acidsInfo
- Publication number
- GB201202497D0 GB201202497D0 GBGB1202497.2A GB201202497A GB201202497D0 GB 201202497 D0 GB201202497 D0 GB 201202497D0 GB 201202497 A GB201202497 A GB 201202497A GB 201202497 D0 GB201202497 D0 GB 201202497D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- substituted
- medicinal applications
- hydroxytetronic acids
- hydroxytetronic
- acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1202497.2A GB201202497D0 (en) | 2012-02-14 | 2012-02-14 | Medicinal applications of substituted hydroxytetronic acids |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1202497.2A GB201202497D0 (en) | 2012-02-14 | 2012-02-14 | Medicinal applications of substituted hydroxytetronic acids |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201202497D0 true GB201202497D0 (en) | 2012-03-28 |
Family
ID=45930064
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1202497.2A Ceased GB201202497D0 (en) | 2012-02-14 | 2012-02-14 | Medicinal applications of substituted hydroxytetronic acids |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201202497D0 (en) |
-
2012
- 2012-02-14 GB GBGB1202497.2A patent/GB201202497D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL287516A (en) | Therapeutic uses of empagliflozin | |
HRP20190101T1 (en) | Therapeutic uses of empagliflozin | |
HK1212701A1 (en) | Formulations of enzalutamide | |
HK1205697A1 (en) | Prodrugs of hydroxyl-comprising drugs | |
HK1213818A1 (en) | Therapeutic uses of empagliflozin | |
HK1210144A1 (en) | New indanyloxydihydrobenzofuranylacetic acids | |
ZA201406082B (en) | Use of ccr3-inhibitors | |
HK1215793A1 (en) | Lyophilized formulation of tat-nr2b9c tat-nr2b9c | |
IL236312A0 (en) | Preparation of 18f-fluciclovine | |
PL2991618T3 (en) | Stable high strength pharmaceutical composition of levoleucovorin | |
EP2898406A4 (en) | Fulfillment of applications to devices | |
EP2881113A4 (en) | New application of pogostone | |
SG11201404881XA (en) | Labeling of medical devices | |
EP2892529A4 (en) | Uses of (-)-perhexiline | |
HK1204916A1 (en) | Pharmaceutical application of anhydroicaritin | |
GB201202497D0 (en) | Medicinal applications of substituted hydroxytetronic acids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |